menu
    • menu

    Company profile for GT Biopharma

    NEW Drugs in Dev: 6
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based our proprietary Tri-specific Killer Engager (TriKE™) platform. Our TriKE platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells). GT Biopharma has an exclusive worldwide license agreement wi...
    GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based our proprietary Tri-specific Killer Engager (TriKE™) platform. Our TriKE platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells). GT Biopharma has an exclusive worldwide license agreement with the University of Minnesota to further develop and commercialize cancer therapies using proprietary TriKE technology developed by researchers at the university to target NK cells to cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GT BiopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9350 Wilshire Blvd Suite 203 Beverly Hills, CA 90212
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.gtbiopharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    GT Biopharma To Participate In The 38th Annual Roth Conference
    GT Biopharma To Participate In The 38th Annual Roth Conference

    11 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/11/3253637/0/en/GT-Biopharma-to-Participate-in-the-38th-Annual-Roth-Conference.html

    GLOBENEWSWIRE
    11 Mar 2026
    Share Share
    GT Biopharma Reports Full Year 2025 Financial Results
    GT Biopharma Reports Full Year 2025 Financial Results

    02 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/02/3247203/0/en/GT-Biopharma-Reports-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    02 Mar 2026
    Share Share
    GT Biopharma to Present at 9th Annual Toronto Growth Conference
    GT Biopharma to Present at 9th Annual Toronto Growth Conference

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3239130/0/en/GT-Biopharma-to-Present-at-the-Centurion-One-Capital-9th-Annual-Toronto-Growth-Conference.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    GT Bio Gets FDA Nod For GTB-5550 Trike For B7-H3 Solid Tumors
    GT Bio Gets FDA Nod For GTB-5550 Trike For B7-H3 Solid Tumors

    03 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/03/3231077/0/en/GT-Biopharma-Announces-FDA-Clearance-of-Investigational-New-Drug-IND-Application-for-GTB-5550-TriKE-a-B7-H3-Targeted-Natural-Killer-NK-Cell-Engager-for-Solid-Tumors-Expressing-B7-H.html

    GLOBENEWSWIRE
    03 Feb 2026
    Share Share
    Functional Force Platforms to Disrupt Tumors by 2026
    Functional Force Platforms to Disrupt Tumors by 2026

    16 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/functional-force-precision-platforms-disrupt-the-2026-tumor-landscape-302663334.html

    PR NEWSWIRE
    16 Jan 2026
    Share Share
    GT Bio Submits IND For B7-H3-Targeted Trike In Solid Tumor Cancer
    GT Bio Submits IND For B7-H3-Targeted Trike In Solid Tumor Cancer

    15 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/15/3219554/0/en/GT-Biopharma-Announces-IND-Submission-for-GTB-5550-TriKE-a-B7-H3-targeted-natural-killer-NK-cell-engager-for-B7-H3-expressing-solid-tumor-cancers.html

    GLOBENEWSWIRE
    15 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search